Skip to main content

Written question asked by Christopher Chope (Conservative) on Thursday, 1 February 2024, in the House of Commons. It was due for an answer on Tuesday, 6 February 2024 (named day). A holding answer was provided on Tuesday, 6 February 2024. A substantive answer was provided by Maria Caulfield (Conservative) on Wednesday, 7 February 2024 on behalf of the Department of Health and Social Care.


Vaccine Damage Payment Scheme

Question

To ask the Secretary of State for Health and Social Care, how many claims on (a) MMR, (b) Covid-19 and (c) all other vaccinations have been made to the Vaccine Damage Payments Scheme in each of the last three years; and how many of each are awaiting a decision as of 1 February 2024.

Answer

In 2021 there were 27 claims related to measles, mumps or rubella (MMR) received by the Vaccine Damage Payment Scheme (VDPS), one of which is still awaiting a decision as of 1 February 2024. Additionally in 2021, 616 claims were received relating to COVID-19, with 42 still awaiting an outcome as of 1 February 2024. 43 claims were received for all other diseases covered by the Vaccine Damage Payment Act (VDPA) 1979, and in this category, seven applications were awaiting an outcome as of 1 February 2024.

In 2022 there were 19 claims related to MMR received by the VDPS, one of which is still awaiting a decision as of 1 February 2024. Furthermore in 2022, 2723 claims were received relating to COVID-19 with 266 still awaiting an outcome as of 1 February 2024. 86 claims were received for all other diseases covered by the VDPA 1979, and of these, 12 applications were still awaiting an outcome as of 1 February 2024.

In 2023 there were five claims related to MMR received by the VDPS, one of which is still awaiting a decision as of 1 February 2024. In this same year, 5383 claims were received relating to COVID-19 with 3519 still awaiting an outcome on 1 February 2024. 222 claims were received for all other diseases covered by the VDPA 1979, and of these, 139 applications were still awaiting an outcome as of 1 February 2024.


Secondary information

Type
Written question
Reference
12505
Session
2023-24
Subjects
MMR vaccine Vaccine damage payment scheme Coronavirus
Contains statistics
Yes
Link
View this Written question on www.parliament.uk